Myocarditis: The immunologist's view on pathogenesis and treatment

Swiss Medical Weekly

Volumn 135, Issue 25-26, 2005, Pages 359-364

  Burian, Julia ^a   Buser, Peter ^a   Eriksson, Urs ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Autoimmunity; Cardiomyopathy; Heart failure; Immunomodulation; Immunosuppression; Myocarditis

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AUTOIMMUNITY; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; DISEASE COURSE; DISEASE SEVERITY; HEART ASSIST DEVICE; HEART EJECTION FRACTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MYOCARDITIS; PATHOGENESIS; POST INFLAMMATORY CARDIOMYOPATHY; SHORT SURVEY; TREATMENT INDICATION; VIRUS MYOCARDITIS;

EID: 23344442150     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (46)

1. Drory Y, Turetz Y, Hiss Y, Lev B, Fisman EZ, Pines A, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 1991;68:1388-92.
2. Wesslen L, Pahlson C, Lindquist O, Hjelm E, Gnarpe J, Larsson E, et al. An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J 1996;17:902-10.
3. Kawai C. From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999;99:1091-100.
4. Pauschinger M, Doerner A, Kuehl U, Schwimmbeck PL, Poller W, Kandolf R, et al. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation 1999;99:889-95.
5. Schofield CJ, Dias JC. The Southern Cone Initiative against Chagas disease. Adv Parasitol 1999;42:1-27.
6. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000;343:1388-98.
7. Jin O, Sole MJ, Butany JW, Chia WK, McLaughlin PR, Liu P et al. Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 1990;82:8-16.
8. Koelsch S, Pankuweit S, Hufnagel G, Maisch B for the ESETCID investigators. The European Study of Epidemiology and Treatment of cardiac inflammatory diseases (ESETCID) - Epidemiological results after 6 years. Annual Meeting of the AHA, New Orleans, november 2004.
9. Cohen JI, Corey GR. Cytomegalovirus infection in the normal host. Medicine (Baltimore) 1985;64:100-14.
10. Pankuweit S, Moll R, Baandrup U, Portig I, Hufnagel G, Maisch B. Prevalence of the parvovirus B 19 genome in endomyocardial biopsy specimens. Hum Pathol 2003;34:497-503.
11. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S. Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 2000;80:1137-42.
12. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation 2003;107:857-63.
13. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, et al. Left ventricular structure and function in children infected with human immunodeficiency virus: the prospective P2C2 HIV Multicenter study. Circulation 1998;97:1246-56.
14. Liu P, Martino T, Opavsky MA, Penninger J. Viral myocarditis: balance between viral infection and immune response. Can J Cardiol 1996;12:935-43.
15. Caforio AL, McKenna WJ. Recognition and optimum management of myocarditis. Drugs 1996;52:515-25.
16. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis - natural history and treatment. Multicenter giant cell myocarditis study group investigators. N Engl J Med 1997;336:1860-66.
17. Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, et al. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999;5:320-26.
18. McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000;342:690-95.
19. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun 2001;16:175-86.
20. Caforio AL, Stewart JT, Bonifacio E, Burke M, Davies MJ, McKenna WJ et al. Inappropriate major histocompatibility expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun 1990;3:187-200.
21. Neumann DA, Burek CL, Baughman KL, Rose NR, Herskowitz A. Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol 1990;16:839-846.
22. Caforio AL, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, et al. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990;15:1527-34.
23. Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenic and clinical significance. Eur J Heart Fail 2002;4:411-17.
24. Lauer B, Schannwell M, Kuhl U, Strauer BE, Schultheiss HP. Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol 2000;35:11-18.
25. Lodge PA, Herzum M, Olszewski, J, Huber SA. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. Am J Pathol 1987;128:455-63.
26. Caforio AL. Role of autoimmunity in dilated cardiomyopathy. Br Heart J 1994;72(Suppl):S30-S34.
27. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003;9:1484-90.
28. Muller J, Wallukat G, Dandel M, Bieda H, Brandes K et al. Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000;101:385-91.
29. Figulla HR. Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction. Med Microbiol Immunol 2003;42:219-25.
30. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol 1987;18:619-24.
31. Chimenti C, Russo A, Pieroni M, Calabrese F, Verardo R, et al. Intramyocyte detection of Epstein-Barr virus genome by laser capture microdissection in patients with inflammatory cardiomyopathy. Circulation 2004;110:3534-39.
32. Parrillo JE, Cunnion RE, Epstein SE, Parker MM, Suffredini AF, Brenner M et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopayhy. N Engl J Med 1989;321:1061-8.
33. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75.
34. Frustaci A, Cuoco L, Chimenti C, Pieroni M, Fioravanti G, Gentiloni N et al. Celiac disease associated with autoimmune myocarditis. Circulation 2002;105:2611-18.
35. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 2001;104:39-45.
36. Kurrer MO, Kopf M, Penninger JM, Eriksson U. Cytokines that regulate autoimmune myocarditis. Swiss Med Wkly 2002;132:408-13.
37. Eriksson U, Kurrer MO, Sonderegger I, Iezzi, G, Tafuri A, Hunziker L, et al. Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J Exp Med 2003;197:323-31.
38. Lenzo JC, Mansfield JP, Sivamoorthy S, Cull VS, James CM. Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy. Cell Immunol 2003;223:77-86.
39. Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, et al. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003;107:2793-8.
40. Louis A, Cleland JG, Crabbe S, Ford S, Thackray S, Houghton T, et al. Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001. Eur J Hear Fail 2001;3:381-7.
41. Kwon HJ, Cote TR, Cuffe MS, Kramer JM, Braun MM. Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 2003;138:807-11.
42. Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: antiinflammatory effects associated with antioxidant property. Am J Physiol Heart Circ Physiol 2004;286:H83-90.
43. Matsui S, Zong ZP, Han JF, Katsuda S, Yamaguchi N, Fu ML. Amiodarone minimizes experimental autoimmune myocarditis in rats. Eur J Pharmacol 2003;469:165-73.
44. Godsel LM, Leon JS, Wang K, Fornek JL, Molteni A, Engman DM. Captopril prevents experimental autoimmune myocarditis. J Immunol 2003;171:346-52
45. Godsel LM, Leon JS, Engman DM. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr Pharm Des 2003;9:723-35.
46. Node K, Fujita M, Kitakaze M, Hori M, Liao JK. Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 2003;108:839-43.